TECH as of Oct 31 · 15:22 ET
TECHNasdaqBiological Products, (No Diagnostic Substances)

Bio-Techne Corp · Brief

Next report

4 days

Nov 4 · before openest.Q1 FY27

Expected move

Inputs

Implied vs realized

8 reportsHistory
2 of 7≥ implied
avg implied
±9.0%
avg realized
±6.7%
Oct 30 '24±8.1%▲+7.46%×0.92
Feb 5 '25±6.8%▲+3.72%×0.54
May 7 '25±9.7%▲+2.16%×0.22
Aug 6 '25±8.6%▼−8.73%×1.01
Nov 5 '25±11.1%▼−1.90%×0.17
Q2 FY26±10.0%▲+6.25%×0.62
Q3 FY26±8.8%▼−16.36%×1.86
Q4 FY26—▲+0.11%—
quarterimplied−20%0+20%realized×
Q4 FY26—▲+0.11%—
Q3 FY26±8.8%▼−16.36%×1.86
Q2 FY26±10.0%▲+6.25%×0.62
Nov '25±11.1%▼−1.90%×0.17
Aug '25±8.6%▼−8.73%×1.01
May '25±9.7%▲+2.16%×0.22
2 older reports
Feb '25±6.8%▲+3.72%×0.54
Oct '24±8.1%▲+7.46%×0.92
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 4 report · est.

Bull2 of 3

598managers reporting a position in the latest quarterly filings13F · Jun 30 '26
51managers whose positions together make up most of the reported value13F · Jun 30 '26

Bear2

9tracked funds holding TECHN-PORT · Aug 31 '26
10 of 23of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

TECH report session
× = co-movement · max 501dSource: SEC filings · market data

Latest changes

30 daysAll changes
Oct 21impliedImplied move: ±6.3% into Nov 4 earnings (Oct 21 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.